We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Debra M. Emerson
Debra M. Emerson
Products
PRODUCTS
CSL Behring, LLC
Debra M. Emerson
,
Claire M. Minden
, and
Prabhu P. Raju
Price:
$117.00
View
Emergent Manufacturing Operations Baltimore, LLC
Debra M. Emerson
,
Cody D. Rickman
, and
Jeremy Wally
Price:
$117.00
View
bluebird bio, Inc.
Debra M. Emerson
and
Alice C. Silva
Price:
$117.00
View
Genzyme Polyclonals SAS
Debra M. Emerson
and
Eileen A. Liu
Price:
$117.00
View
GenTrac, Inc.
Debra M. Emerson
,
Peter Kessler
, and
Ze Peng
Price:
$117.00
View
Wyeth BioPharma, Division of Wyeth Pharmaceuticals, Inc.
Debra M. Emerson
Price:
$117.00
View
CSL Behring LLC
Debra M. Emerson
and
Susan M. Jackson
Price:
$117.00
View
Barr Laboratories, Inc.
Debra M. Emerson
Price:
$117.00
View
Novo Nordisk A/S
Debra M. Emerson
and
Simone E. Pitts
Price:
$117.00
View
GlaxoSmithKline Biologicals
Debra M. Emerson
,
Dino A. Feigelstock
, and
Omotunde O. Osunsanmi
Price:
$117.00
View
View All Products by Debra M. Emerson
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
10
Aug
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek
Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher
FDA Approves Beyond Air’s LungFit PH for Newborn Pulmonary Hypertension
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
